Hamad Medical Corporation (HMC) has signed a Memorandum of Understanding (MoU) with the Qatar Biomedical Research Institute (QBRI), formalizing an agreement that will see both entities harness their combined medical research capabilities.
The agreement will also further enhance an environment in which clinical discoveries will be translated into practical applications for the benefit of patients more quickly.
The MoU was signed by HMC’s Managing Director, Hanan Al Kuwari, PhD and QBRI Executive Director, Dr. Hilal Lashuel. The new agreement will boost the resources of existing research teams studying health problems like diabetes, cancer, degenerative diseases and genetic disorders and pave the way for new research studies.
View the full press release here
(English) or here
(Arabic). The Gulf Times article is available here